Prescription Opioid Analgesics Increase the Risk of Depression
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Prescription opioid analgesic use has quintupled recently. Evidence linking opioid use with depression emanates from animal models and studies of persons with co-occurring substance use and major depression. Little is known about depressogenic effects of opioid use in other populations.
The purpose of this study was to determine whether prescription opioids are associated with increased risk of diagnosed depression.
Retrospective cohort study, new user design.
Medical record data from 49,770 US Department of Veterans Affairs (VA) health care system patients with no recent (24-month) history of opioid use or a diagnosis of depression in 1999 and 2000.
Propensity scores were used to control for bias by indication, and the data were weighted to balance the distribution of covariates by duration of incident opioid exposure. Cox proportional hazard models with adjustment for painful conditions were used to estimate the association between duration of prescription opioid use and the subsequent risk of development of depression between 2001 and 2007.
Of 49,770 patients who were prescribed an opioid analgesic, 91 % had a prescription for < 90 days, 4 % for 90–180 days, and 5 % for > 180 days. Compared to patients whose prescription was for < 90 days, the risk of depression increased significantly as the duration of opioid prescription increased (HR = 1.25; 95 % CI: 1.05–1.46 for 90–180 days, and HR = 1.51; 95 % CI:1.31–1.74 for > 180 days).
In this sample of veterans with no recent (24-month) history of depression or opioid analgesic use, the risk of development of depression increased as the duration of opioid analgesic exposure increased. The potential for depressogenic effect should be considered in risk-benefit discussions, and patients initiating opioid treatment should be monitored for development of depression.
- Hall, AJ, Logan, JE, Toblin, RL (2008) Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 300: pp. 2613-2620 CrossRef
- Caudill-Slosberg, MA, Schwartz, LM, Woloshin, S (2004) Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000. Pain 109: pp. 514-519 CrossRef
- Ballantyne, JC, Mao, J (2003) Opioid therapy for chronic pain. N Engl J Med 349: pp. 1943-1953 CrossRef
- Cicero, T, Inciardi, JA, Munoz, A (2005) Trends in abuse of Oxycontin and other opioid analgesics in the United States 2002–2004. J Pain 6: pp. 662-672 CrossRef
- Kluger J. The new drug crisis: addiction by prescription. Time 2010:46–9.
- Cole, BE (2011) The need for chronic opioids to treat persistent noncancer pain. Gen Hosp Psychiatry 33: pp. 419-422 CrossRef
- Morrison, RS, Magaziner, J, Gilbert, M, Koval, KJ, McLaughlin, MA, Orosz, G, Strauss, E, Siu, AL (2003) Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci 58: pp. 76-81 CrossRef
- Results from the 2010 National Survey on Drug Use and Health. In: Administration SAMHSA, ed. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011.
- Dodrill, CL, Helmer, DA, Kosten, TR (2011) Prescription pain medication dependence. Am J Psychiatry 168: pp. 466-471 CrossRef
- Department of Health & Human Services CfDCaP. Unintentional Drug Poisoning in the United States; 2010.
- Jackson, SW (1986) Melancholia and depression: from hippocratic times to modern times. Yale University Press, New Haven, CT
- Pfeiffer, A, Brantl, V, Herz, A, Emrich, HM (1986) Psychotomimesis mediated by kappa opiate recepters. Science 233: pp. 774-776 CrossRef
- Grattan, A, Sullivan, M, Saunders, K, Campbell, C, Korff, M (2012) Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med 10: pp. 304-311 CrossRef
- Reid, MC, Engles-Horton, LL, Weber, MB, Kerns, RD, Rogers, EL, O’Connor, PG (2002) Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 17: pp. 173-179 CrossRef
- Sullivan, MD, Edlund, MJ, Zhang, L, Unutzer, J, Wells, KB (2006) Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 166: pp. 2087-2093 CrossRef
- Braden, JB, Sullivan, MD, Ray, GT (2009) Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psych 31: pp. 564-570 CrossRef
- Volkow, ND (2001) Drug abuse and mental illness: progress in understanding comorbidity. Am J Psychiatry 158: pp. 1181-1183 CrossRef
- Edlund, M, Martine, BC, Fan, MY, Brennan Braden, J, Deveries, A, Sullivan, MD (2010) An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP study. J Pain Symptom Manage 40: pp. 279-289 CrossRef
- Volkow, ND (2004) The reality of comorbidity: depression and drug abuse. Biol Psychiatry 56: pp. 714-717 CrossRef
- Oxycodone and acetaminophen: drug information. In: Lexicomp, Inc; 2012.
- Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR). Fourth Edition. Washington DC: American Psychiatric Association; 2000.
- Fishbain, D, Cutler, R, Rosomoff, H, Rosomoff, RS (1997) Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 13: pp. 116-137 CrossRef
- Heinze, G, Juni, P (2011) An overview of the objectives and the approaches to propensity score analysis. Eur Heart J 32: pp. 1704-1708 CrossRef
- Frayne SM, Miller DR, Sharkansky EJ, Jackson VW, Wang F, Halanych JH, Berlowitz DR, Kader B, Rosen CS, Keane TM. Using administrative data to identify mental illness: what approach is best? American Journal of Medical Quality 2010;25:42–50.
- Solberg LI, Engebretson KI, Sperl-Hillen JM, Hroscikoski MC, O'Connor PJ. Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. American Journal of Medical Quality 2006;21:238-245.
- Rosenbaum, PR, Rubin, DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70: pp. 41-55 CrossRef
- Williamson, E, Morley, R, Lucas, A, Carpenter, J (2012) Propensity scores: From naive enthusiasm to inituitive understanding. Stat Methods Med Res 21: pp. 273-293 CrossRef
- Cole, SR, Hernan, MA (2008) Constructing inverse probability weights for marginal structural models. Am J Epidemiol 168: pp. 656-664 CrossRef
- Curtis, LH, Hammill, BG, Eisenstein, EL, Kramer, JM, Anstrom, KJ (2007) Using inverse probability-weighted estimators in comparative effectiveness analysis with observational databases. Med Care 45: pp. S103-S107 CrossRef
- Kilpatrick, RD, Gilberston, D, Brookhart, MA, Polley, E, Rothman, KJ, Bradbury, BD (2013) Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rate treatment decisions. Pharmacoepidemiol Drug Saf 22: pp. 111-121 CrossRef
- Seal, KH, Shi, Y, Cohen, G (2012) Association of mental health disorders with prescription opioids and high-risk opioid use in US Veterans of Iraq and Afghanistan. JAMA 307: pp. 940-947
- Healy, D (2010) Pharmageddon. University of California Press, Berkley and Los Angeles
- Hyman, SE, Malenka, RC, Nestler, EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: pp. 565-598 CrossRef
- Robinson, TE, Kolb, B (2004) Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47: pp. 33-46 CrossRef
- Spanagel, R, Shipenberg, TS (1993) Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat. Neurosci Lett 153: pp. 232-236 CrossRef
- George, S, Murali, V, Pullickal, R (2005) Review of neuroendocrine correlates of chronic opiate misuse: dysfunctions and pathophysiological mechanisms. Addic Dis Treat 4: pp. 99-109 CrossRef
- Schaffer, CB, Nordahl, TE, Schaffer, LC, Howe, J (2007) Mood-elevating effects of opioid analgesics in patients with bipolar disorder. J Neuropsychiatry Clin Neurosci 19: pp. 449-452 CrossRef
- Schneeweiss, S (2006) Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf 15: pp. 291-303 CrossRef
- Psaty, BM, Koepsell, TD, Lin, D (1999) Assessment and control for confounding by indication in obsrvational studies. J Am Geriatr Soc 47: pp. 749-754
- Prescription Opioid Analgesics Increase the Risk of Depression
Journal of General Internal Medicine
Volume 29, Issue 3 , pp 491-499
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- prescription opioid analgesics
- propensity score
- administrative medical records
- Industry Sectors
- Author Affiliations
- 1. Research Service, Clinical Research and Epidemiology Workgroup, St. Louis VA Medical Center, St. Louis, MO, USA
- 2. Department of Family and Community Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA
- 3. Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
- 4. The Bell Street Clinic, John Cochran Hospital, St. Louis VA Medical Center, St. Louis, MO, USA
- 5. Massachusetts Veterans Epidemiology Research and Information Center, VA Cooperative Studies Program, VA Boston Healthcare System, Jamaica Plain, MA, USA
- 6. Harvard Medical School and Division of Aging, Brigham and Women’s Hospital, Boston, MA, USA